Get the SPI Wire

MIRA Pharmaceuticals, Inc.

NASDAQ:MIRA
Annual Meeting

of Shareholders

MEETING DATE

09/11/2026
DEF 14A FILED
07/28/2026
PUBLISHED
07/28/2026 9:00 pm
TIME TO PUBLISH
07/30/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:MIRA · CUSIP 60458C104 · CLASS common stock, par value $0.0001 per share · CIK 0001904286

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated five directors, and the filing discloses no board opposition or nominee unavailability.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Appointment of Independent Registered Public Accounting Firm
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Audit Committee appointed Salberg, and the filing discloses no auditor independence or accounting concerns.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of the Adjournment
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment would permit further solicitation if votes are insufficient to approve Proposals 1 and 2.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

8afa230b16233f17f3ff2ba9e0abce2b7a9b6db099731cbfe9df6fa182470313

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates